{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:14:49Z","timestamp":1742948089093,"version":"3.40.3"},"reference-count":109,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443342929"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.apha.2024.12.001","type":"book-chapter","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T20:40:05Z","timestamp":1736973605000},"page":"1-26","source":"Crossref","is-referenced-by-count":1,"title":["Targeting PAAN\/MIF nuclease activity in parthanatos-associated brain diseases"],"prefix":"10.1016","author":[{"given":"Lauren C.","family":"Guttman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meilian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valina L.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted M.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"44","key":"10.1016\/bs.apha.2024.12.001_bib1","doi-asserted-by":"crossref","first-page":"36541","DOI":"10.1074\/jbc.C500243200","article-title":"ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis","volume":"280","author":"Al-Abed","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.apha.2024.12.001_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101546","article-title":"Targeting low levels of MIF expression as a potential therapeutic strategy for ALS","volume":"5","author":"Alfahel","year":"2024","journal-title":"Cell Reports Medicine"},{"issue":"5","key":"10.1016\/bs.apha.2024.12.001_bib3","article-title":"Traumatic brain injury: A perspective on the silent epidemic","volume":"13","author":"Alkhaibary","year":"2021","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/bs.apha.2024.12.001_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"15","key":"10.1016\/bs.apha.2024.12.001_bib5","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1073\/pnas.93.15.7849","article-title":"An essential regulatory role for macrophage migration inhibitory factor in T-cell activation","volume":"93","author":"Bacher","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.apha.2024.12.001_bib6","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199356","article-title":"Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer\u2019s disease","volume":"16","author":"Bader","year":"2020","journal-title":"Molecular Systems Biology"},{"issue":"36","key":"10.1016\/bs.apha.2024.12.001_bib7","doi-asserted-by":"crossref","first-page":"30653","DOI":"10.1074\/jbc.M112.385583","article-title":"A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF)","volume":"287","author":"Bai","year":"2012","journal-title":"Journal of Biological Chemistry"},{"issue":"11-12","key":"10.1016\/bs.apha.2024.12.001_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.18071\/isz.74.0379","article-title":"Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias","volume":"74","author":"Balazs","year":"2021","journal-title":"Ideggyogyaszati Szemle"},{"issue":"49","key":"10.1016\/bs.apha.2024.12.001_bib9","doi-asserted-by":"crossref","first-page":"15356","DOI":"10.1021\/bi971153a","article-title":"Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor","volume":"36","author":"Bendrat","year":"1997","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/bs.apha.2024.12.001_bib10","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: A report from the american heart association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0006-8993(03)03362-6","article-title":"Deleterious poly(ADP-ribose)polymerase-1 pathway activation in traumatic brain injury in rat","volume":"989","author":"Besson","year":"2003","journal-title":"Brain Research"},{"key":"10.1016\/bs.apha.2024.12.001_bib12","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.1038\/nrdp.2016.84","article-title":"Traumatic brain injuries","volume":"2","author":"Blennow","year":"2016","journal-title":"Nature Reviews Disease Primers"},{"issue":"12","key":"10.1016\/bs.apha.2024.12.001_bib13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1080\/14728222.2016.1251582","article-title":"MIF, a controversial cytokine: A review of structural features, challenges, and opportunities for drug development","volume":"20","author":"Bloom","year":"2016","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2010.09.005","article-title":"Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus: Evidence in Parkinson\u2019s disease patients","volume":"41","author":"Burguillos","year":"2011","journal-title":"Neurobiology of Disease"},{"issue":"6544","key":"10.1016\/bs.apha.2024.12.001_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoid-induced modulator of cytokine production","volume":"377","author":"Calandra","year":"1995","journal-title":"Nature"},{"issue":"10","key":"10.1016\/bs.apha.2024.12.001_bib16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: A regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nature Reviews. Immunology"},{"issue":"8","key":"10.1016\/bs.apha.2024.12.001_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134482","article-title":"PARP-1 inhibition is neuroprotective in the R6\/2 mouse model of Huntington\u2019s disease","volume":"10","author":"Cardinale","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2024.12.001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104700","article-title":"Autonomic dysfunction in Parkinson\u2019s disease: Implications for pathophysiology, diagnosis, and treatment","volume":"134","author":"Chen","year":"2020","journal-title":"Neurobiology of Disease"},{"issue":"12","key":"10.1016\/bs.apha.2024.12.001_bib19","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1080\/15548627.2020.1719723","article-title":"Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice","volume":"16","author":"Cheng","year":"2020","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib20","first-page":"S19","article-title":"25 Years on: A retrospective on migration inhibitory factor in tumor angiogenesis","volume":"21","author":"Chesney","year":"2015","journal-title":"Molecular Medicine (Cambridge, Mass.)"},{"issue":"5","key":"10.1016\/bs.apha.2024.12.001_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Collaborators","year":"2019","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1016\/bs.apha.2024.12.001_bib22","first-page":"416","article-title":"Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening","volume":"52","author":"Cournia","year":"2009","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apha.2024.12.001_bib23","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.4049\/jimmunol.1200485","article-title":"Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation","volume":"191","author":"Cox","year":"2013","journal-title":"Journal of Immunology"},{"issue":"8","key":"10.1016\/bs.apha.2024.12.001_bib24","first-page":"504","article-title":"Parkinson\u2019s disease and its management: Part 1: Disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis","volume":"40","author":"DeMaagd","year":"2015","journal-title":"P T"},{"issue":"4","key":"10.1016\/bs.apha.2024.12.001_bib25","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2019","journal-title":"Journal of Neurosurgery"},{"issue":"3","key":"10.1016\/bs.apha.2024.12.001_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41422-019-0141-z","article-title":"PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins","volume":"29","author":"Duan","year":"2019","journal-title":"Cell Research"},{"key":"10.1016\/bs.apha.2024.12.001_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2018.06.009","article-title":"Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences","volume":"322","author":"Fagone","year":"2018","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/bs.apha.2024.12.001_bib28","doi-asserted-by":"crossref","first-page":"13416","DOI":"10.1038\/srep13416","article-title":"Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions","volume":"5","author":"Farrawell","year":"2015","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1016\/bs.apha.2024.12.001_bib29","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/bph.12416","article-title":"Parthanatos: Mitochondrial-linked mechanisms and therapeutic opportunities","volume":"171","author":"Fatokun","year":"2014","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1016\/bs.apha.2024.12.001_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.937133","article-title":"Neuronal cell death mechanisms in Alzheimer\u2019s disease: An insight","volume":"15","author":"Goel","year":"2022","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"3","key":"10.1016\/bs.apha.2024.12.001_bib32","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"P T"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pharmrev.120.000133","article-title":"Therapeutics in the pipeline targeting alpha-synuclein for Parkinson\u2019s disease","volume":"74","author":"Grosso Jasutkar","year":"2022","journal-title":"Pharmacological Reviews"},{"issue":"3","key":"10.1016\/bs.apha.2024.12.001_bib34","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41557-018-0187-4","article-title":"Rapamycin-inspired macrocycles with new target specificity","volume":"11","author":"Guo","year":"2019","journal-title":"Nature Chemistry"},{"issue":"47","key":"10.1016\/bs.apha.2024.12.001_bib35","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2018.33.e300","article-title":"Psychiatric manifestation in patients with Parkinson\u2019s disease","volume":"33","author":"Han","year":"2018","journal-title":"Journal of Korean Medical Science"},{"key":"10.1016\/bs.apha.2024.12.001_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120320","article-title":"MIF in the cerebrospinal fluid is decreased during relapsing-remitting while increased in secondary progressive multiple sclerosis","volume":"439","author":"Hjaeresen","year":"2022","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12974-023-02796-9","article-title":"Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer\u2019s disease","volume":"20","author":"Hok","year":"2023","journal-title":"Journal of Neuroinflammation"},{"issue":"5","key":"10.1016\/bs.apha.2024.12.001_bib38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41419-022-04918-2","article-title":"Macrophage migration inhibitory factor (MIF) acetylation protects neurons from ischemic injury","volume":"13","author":"Hu","year":"2022","journal-title":"Cell Death & Disease"},{"issue":"3","key":"10.1016\/bs.apha.2024.12.001_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152498","article-title":"The effects of pharmacological inhibition of histone deacetylase 3 (HDAC3) in Huntington\u2019s disease mice","volume":"11","author":"Jia","year":"2016","journal-title":"PLoS One"},{"issue":"6414","key":"10.1016\/bs.apha.2024.12.001_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8407","article-title":"Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson\u2019s disease","volume":"362","author":"Kam","year":"2018","journal-title":"Science (New York, N. Y.)"},{"issue":"7","key":"10.1016\/bs.apha.2024.12.001_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","article-title":"The immunobiology of MIF: Function, genetics and prospects for precision medicine","volume":"15","author":"Kang","year":"2019","journal-title":"Nature Reviews Rheumatology"},{"issue":"7","key":"10.1016\/bs.apha.2024.12.001_bib42","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/15376516.2023.2202730","article-title":"Combination of acetylcholinesterase inhibitors and NMDA receptor antagonists increases survival rate in soman-poisoned mice","volume":"33","author":"Kassa","year":"2023","journal-title":"Toxicology Mechanisms and Methods"},{"key":"10.1016\/bs.apha.2024.12.001_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.662034","article-title":"Targeting parthanatos in ischemic stroke","volume":"12","author":"Koehler","year":"2021","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/bs.apha.2024.12.001_bib44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1471-2105-6-172","article-title":"The PD-(D\/E)XK superfamily revisited: Identification of new members among proteins involved in DNA metabolism and functional predictions for domains of (hitherto) unknown function","volume":"6","author":"Kosinski","year":"2005","journal-title":"BMC Bioinformatics"},{"issue":"40","key":"10.1016\/bs.apha.2024.12.001_bib45","doi-asserted-by":"crossref","first-page":"29641","DOI":"10.1074\/jbc.M601103200","article-title":"Human macrophage migration inhibitory factor: A proven immunomodulatory cytokine?","volume":"281","author":"Kudrin","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.apha.2024.12.001_bib46","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/nar\/gkq958","article-title":"Identification of new homologs of PD-(D\/E)XK nucleases by support vector machines trained on data derived from profile-profile alignments","volume":"39","author":"Laganeckas","year":"2011","journal-title":"Nucleic Acids Research"},{"issue":"10","key":"10.1016\/bs.apha.2024.12.001_bib47","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nn.3500","article-title":"Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss","volume":"16","author":"Lee","year":"2013","journal-title":"Nature Neuroscience"},{"issue":"29","key":"10.1016\/bs.apha.2024.12.001_bib48","doi-asserted-by":"crossref","first-page":"14755","DOI":"10.1073\/pnas.1904665116","article-title":"AAV2\/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS","volume":"116","author":"Leyton-Jaimes","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.apha.2024.12.001_bib49","first-page":"415","article-title":"Crystal structure of macrophage migration inhibitory factor (MIF), a glucocorticoid-induced regulator of cytokine production, reveals a unique architecture","volume":"108","author":"Lolis","year":"1996","journal-title":"Proceedings of the Association of American Physicians"},{"issue":"Pt 2","key":"10.1016\/bs.apha.2024.12.001_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/brain\/122.2.247","article-title":"Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer\u2019s disease","volume":"122","author":"Love","year":"1999","journal-title":"Brain"},{"issue":"28","key":"10.1016\/bs.apha.2024.12.001_bib51","doi-asserted-by":"crossref","first-page":"24976","DOI":"10.1074\/jbc.M203220200","article-title":"The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents","volume":"277","author":"Lubetsky","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/bs.apha.2024.12.001_bib52","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bbamcr.2009.09.007","article-title":"Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation","volume":"1793","author":"Lugrin","year":"2009","journal-title":"Biochimica et Biophysica Acta"},{"issue":"40","key":"10.1016\/bs.apha.2024.12.001_bib53","article-title":"Poly ADP-ribose signaling is dysregulated in Huntington disease","volume":"121","author":"Maiuri","year":"2024","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.apha.2024.12.001_bib54","first-page":"395","article-title":"Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex","volume":"26","author":"Maiuri","year":"2017","journal-title":"Human Molecular Genetics"},{"issue":"8","key":"10.1016\/bs.apha.2024.12.001_bib55","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1111\/febs.15716","article-title":"The role of PARP1 in neurodegenerative diseases and aging","volume":"289","author":"Mao","year":"2022","journal-title":"The FEBS Journal"},{"issue":"8","key":"10.1016\/bs.apha.2024.12.001_bib56","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart disease and stroke statistics: A report of US and global data from the American heart association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12974-023-02993-6","article-title":"MIF contribution to progressive brain diseases","volume":"21","author":"Matejuk","year":"2024","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40478-018-0586-1","article-title":"Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis","volume":"6","author":"McGurk","year":"2018","journal-title":"Acta Neuropathologica Communications"},{"issue":"4","key":"10.1016\/bs.apha.2024.12.001_bib59","doi-asserted-by":"crossref","DOI":"10.1177\/2055217319894604","article-title":"PARP-1 deregulation in multiple sclerosis","volume":"5","author":"Meira","year":"2019","journal-title":"Multiple Sclerosis Journal \u2013 Experimental, Translational and Clinical"},{"issue":"34","key":"10.1016\/bs.apha.2024.12.001_bib60","first-page":"E577","article-title":"The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF)","volume":"108","author":"Merk","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/bs.apha.2024.12.001_bib61","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.4049\/jimmunol.154.8.3863","article-title":"Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF)","volume":"154","author":"Mitchell","year":"1995","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1073\/pnas.012511599","article-title":"Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response","volume":"99","author":"Mitchell","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2024.12.001_bib63","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fncel.2019.00528","article-title":"Traumatic brain injuries: Pathophysiology and potential therapeutic targets","volume":"13","author":"Ng","year":"2019","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2024.12.001_bib64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cyto.2011.03.027","article-title":"Parkinson\u2019s disease is associated with increased serum levels of macrophage migration inhibitory factor","volume":"55","author":"Nicoletti","year":"2011","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/bs.apha.2024.12.001_bib65","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2006.07.044","article-title":"AIF translocates to the nucleus in the spinal motor neurons in a mouse model of ALS","volume":"406","author":"Oh","year":"2006","journal-title":"Neuroscience Letters"},{"issue":"11","key":"10.1016\/bs.apha.2024.12.001_bib66","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.cell.2022.04.020","article-title":"PAAN\/MIF nuclease inhibition prevents neurodegeneration in Parkinson\u2019s disease","volume":"185","author":"Park","year":"2022","journal-title":"Cell"},{"unstructured":"Parkinson disease. (2023). Retrieved from. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/parkinson-disease. from World Health Organization https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/parkinson-disease.","key":"10.1016\/bs.apha.2024.12.001_bib67"},{"issue":"3","key":"10.1016\/bs.apha.2024.12.001_bib68","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mds.28382","article-title":"Levodopa versus dopamine agonist after subthalamic stimulation in Parkinson\u2019s disease","volume":"36","author":"Picillo","year":"2021","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"4","key":"10.1016\/bs.apha.2024.12.001_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040415","article-title":"Chronic traumatic encephalopathy: Update on current clinical diagnosis and management","volume":"9","author":"Pierre","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/bs.apha.2024.12.001_bib70","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/pharmrev.120.000189","article-title":"Parkinson disease: Translating insights from molecular mechanisms to neuroprotection","volume":"73","author":"Pirooznia","year":"2021","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.apha.2024.12.001_bib71","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nature Reviews Disease Primers"},{"issue":"3","key":"10.1016\/bs.apha.2024.12.001_bib72","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","article-title":"Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: A review of the literature","volume":"10","author":"Ramesh","year":"2023","journal-title":"AIMS Neurosciences"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-5793(97)01261-1","article-title":"The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase","volume":"417","author":"Rosengren","year":"1997","journal-title":"FEBS Letters"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib74","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00018-021-04037-9","article-title":"MIF promotes neurodegeneration and cell death via its nuclease activity following traumatic brain injury","volume":"79","author":"Ruan","year":"2021","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib75","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/nar\/gkt835","article-title":"PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS\/TLS to sites of oxidative DNA damage","volume":"42","author":"Rulten","year":"2014","journal-title":"Nucleic Acids Research"},{"issue":"6","key":"10.1016\/bs.apha.2024.12.001_bib76","first-page":"1133","article-title":"An overview of the effects of levodopa and dopaminergic agonists on sleep disorders in Parkinson\u2019s disease","volume":"19","author":"Scanga","year":"2023","journal-title":"Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2024.12.001_bib77","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41419-017-0130-4","article-title":"MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS","volume":"9","author":"Shvil","year":"2018","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.apha.2024.12.001_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.707723","article-title":"Different catechol-o-methyl transferase inhibitors in Parkinson\u2019s disease: A Bayesian network meta-analysis","volume":"12","author":"Song","year":"2021","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","article-title":"The role of TDP-43 mislocalization in amyotrophic lateral sclerosis","volume":"15","author":"Suk","year":"2020","journal-title":"Molecular Neurodegeneration"},{"issue":"10","key":"10.1016\/bs.apha.2024.12.001_bib80","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: New insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nature Reviews Neurology"},{"issue":"9","key":"10.1016\/bs.apha.2024.12.001_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6609a1","article-title":"Traumatic brain injury-related emergency department visits, hospitalizations, and deaths \u2013 United States, 2007 and 2013","volume":"66","author":"Taylor","year":"2017","journal-title":"MMWR. Surveillance Summaries: Morbidity and Mortality Weekly Report. Surveillance Summaries\/CDC"},{"issue":"18","key":"10.1016\/bs.apha.2024.12.001_bib82","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1021\/acs.jmedchem.8b00589","article-title":"Advances and insights for small molecule inhibition of macrophage migration inhibitory factor","volume":"61","author":"Trivedi-Parmar","year":"2018","journal-title":"Journal of Medicinal Chemistry"},{"issue":"8","key":"10.1016\/bs.apha.2024.12.001_bib83","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: A report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/bs.apha.2024.12.001_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100534","article-title":"Proteomic analysis of Huntington\u2019s disease medium spiny neurons identifies alterations in lipid droplets","volume":"22","author":"Tshilenge","year":"2023","journal-title":"Molecular & Cellular Proteomics: MCP"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib85","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/med.21817","article-title":"Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications","volume":"42","author":"Tuo","year":"2022","journal-title":"Medicinal Research Reviews"},{"issue":"3","key":"10.1016\/bs.apha.2024.12.001_bib86","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1176\/appi.psy.50.3.198","article-title":"Neuropsychiatric problems after traumatic brain injury: Unraveling the silent epidemic","volume":"50","author":"Vaishnavi","year":"2009","journal-title":"Psychosomatics"},{"issue":"Pt 3","key":"10.1016\/bs.apha.2024.12.001_bib87","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/brain\/awp337","article-title":"Inhibiting poly(ADP-ribose) polymerase: A potential therapy against oligodendrocyte death","volume":"133","author":"Veto","year":"2010","journal-title":"Brain"},{"issue":"3","key":"10.1016\/bs.apha.2024.12.001_bib88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-004-0957-5","article-title":"Expression pattern of apoptosis-related markers in Huntington\u2019s disease","volume":"109","author":"Vis","year":"2005","journal-title":"Acta Neuropathologica"},{"issue":"5","key":"10.1016\/bs.apha.2024.12.001_bib89","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12975-022-01090-9","article-title":"Reinventing the penumbra \u2013 The emerging clockwork of a multi-modal mechanistic paradigm","volume":"14","author":"Walther","year":"2023","journal-title":"Translational Stroke Research"},{"issue":"6308","key":"10.1016\/bs.apha.2024.12.001_bib90","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad6872","article-title":"A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1","volume":"354","author":"Wang","year":"2016","journal-title":"Science (New York, N. Y.)"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib91","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1038\/s41467-021-23264-z","article-title":"MIF is a 3\u2019 flap nuclease that facilitates DNA replication and promotes tumor growth","volume":"12","author":"Wang","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/bs.apha.2024.12.001_bib92","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2020.09.049","article-title":"Parthanatos in the pathogenesis of nervous system diseases","volume":"449","author":"Wang","year":"2020","journal-title":"Neuroscience"},{"issue":"167","key":"10.1016\/bs.apha.2024.12.001_bib93","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2000902","article-title":"Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos)","volume":"4","author":"Wang","year":"2011","journal-title":"Science Signaling"},{"issue":"5598","key":"10.1016\/bs.apha.2024.12.001_bib94","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1126\/science.1076194","article-title":"Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans","volume":"298","author":"Wang","year":"2002","journal-title":"Science (New York, N. Y.)"},{"issue":"19","key":"10.1016\/bs.apha.2024.12.001_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202201390","article-title":"Fluorination and betaine modification augment the blood-brain barrier-crossing ability of cylindrical polymer brushes","volume":"61","author":"Wang","year":"2022","journal-title":"Angewandte Chemie (International Ed. in English)"},{"issue":"48","key":"10.1016\/bs.apha.2024.12.001_bib96","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1523\/JNEUROSCI.3461-04.2004","article-title":"Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death","volume":"24","author":"Wang","year":"2004","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41531-022-00295-x","article-title":"Gastrointestinal involvement in Parkinson\u2019s disease: Pathophysiology, diagnosis, and management","volume":"8","author":"Warnecke","year":"2022","journal-title":"npj Parkinson\u2019s Disease"},{"key":"10.1016\/bs.apha.2024.12.001_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106314","article-title":"Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities","volume":"187","author":"Xu","year":"2023","journal-title":"Neurobiology of Disease"},{"issue":"35","key":"10.1016\/bs.apha.2024.12.001_bib99","doi-asserted-by":"crossref","first-page":"10138","DOI":"10.1021\/acs.jafc.1c03367","article-title":"Identification and structure-activity relationships of dietary flavonoids as human macrophage migration inhibitory factor (MIF) inhibitors","volume":"69","author":"Yang","year":"2021","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.1016\/bs.apha.2024.12.001_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116174","article-title":"Parthanatos: mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke","author":"Yang","year":"2024","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/bs.apha.2024.12.001_bib101","doi-asserted-by":"crossref","first-page":"128445","DOI":"10.1016\/j.bmcl.2021.128445","article-title":"Repurposing old drugs as novel inhibitors of human MIF from structural and functional analysis","volume":"55","author":"Yang","year":"2022","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/bs.apha.2024.12.001_bib102","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2017.03.030","article-title":"Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury","volume":"469","author":"Yang","year":"2017","journal-title":"Clinica Chimica Acta; International Journal of Clinical Chemistry"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib103","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1752-2897-2-5","article-title":"The profile of head injuries and traumatic brain injury deaths in Kashmir","volume":"2","author":"Yattoo","year":"2008","journal-title":"Journal of Trauma Management and Outcomes"},{"issue":"48","key":"10.1016\/bs.apha.2024.12.001_bib104","doi-asserted-by":"crossref","first-page":"18314","DOI":"10.1073\/pnas.0606528103","article-title":"Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death","volume":"103","author":"Yu","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10.1016\/bs.apha.2024.12.001_bib105","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41419-021-03926-y","article-title":"Parp mutations protect from mitochondrial toxicity in Alzheimer\u2019s disease","volume":"12","author":"Yu","year":"2021","journal-title":"Cell Death & Disease"},{"issue":"5579","key":"10.1016\/bs.apha.2024.12.001_bib106","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1126\/science.1072221","article-title":"Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor","volume":"297","author":"Yu","year":"2002","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.apha.2024.12.001_bib107","doi-asserted-by":"crossref","DOI":"10.2991\/978-94-6463-556-0","article-title":"Exploring the role of parthanatos in CNS injury: Molecular insights and therapeutic approaches","author":"Zhang","year":"2024","journal-title":"Journal of Advanced Research"},{"issue":"6","key":"10.1016\/bs.apha.2024.12.001_bib108","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41401-021-00753-x","article-title":"Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays","volume":"43","author":"Zhang","year":"2022","journal-title":"Acta Pharmacologica Sinica"},{"issue":"1","key":"10.1016\/bs.apha.2024.12.001_bib109","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13195-019-0508-x","article-title":"Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer\u2019s disease","volume":"11","author":"Zhang","year":"2019","journal-title":"Alzheimer\u2019s Research & Therapy"}],"container-title":["Advances in Pharmacology","Targeting Enzymes in the Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358924000632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358924000632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T01:07:07Z","timestamp":1740532027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358924000632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443342929"],"references-count":109,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2024.12.001","relation":{},"ISSN":["1054-3589"],"issn-type":[{"type":"print","value":"1054-3589"}],"subject":[],"published":{"date-parts":[[2025]]}}}